In the News January 5, 2021

Inside Health Policy | FDA Inspection Plans Unclear as EUAs Move toward Full Approvals

Cathy Burgess is quoted on how the Food and Drug Administration might conduct remote inspections of drug manufacturing facilities amid COVID-19.
Media Contact
Alex Wolfe
Communications Director